Hepatitis C: a projection of the healthcare and economic burden in the UK
Source
This report assesses the healthcare and economic burden of the hepatitis C virus (HCV) infection in the UK. It used a cohort simulation model to estimate the prevalence of HCV infection, including the number of persons who live with HCV infection at different disease stages, and the number of deaths that can be attributed to HCV infection through to 2035. It also examines the healthcare and societal costs that are associated with HCV infection under different scenarios of diagnosis and treatment rates.
No comments:
Post a Comment